Clinical Trials Browser

Phase 4 × Unknown × Neoadjuvant Therapy × Clear all

NCT06003673 2023-10-24

A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT01868828 2013-06-06

A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma

Phase 4 Unknown

Multiple Myeloma